Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK0524 (laropiprant) for niacin-induced flushing
NCT00536237Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Aug 2004
- Primary completion
- Feb 2005
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of laropiprant, sponsored by Merck & Co.. Started Aug 2004; status: completed.
02
Drugs
laropiprant
Beyond the preview
Go deeper on NCT00536237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00536237.